33 results
8-K
EX-2.2
KA
Kineta Inc
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm
Agreements, Contracts and Commitments
2.10
Liabilities
2.11
Compliance; Permits; Restrictions
2.12
Anti-Corruption Compliance; Trade Control Laws … and Commitments
3.8
Liabilities
3.9
Compliance; Permits; Restrictions
3.10
Anti-Corruption Compliance; Trade Control Laws and Sanctions
3.11
Tax Matters
8-K
EX-2.6
KA
Kineta Inc
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm
business.
2.17 Anti-Corruption Laws. In the last three years, none of the Company or any of its subsidiaries, or any director, officer, or employee … official action, or to any person in violation in any material respect of any applicable anti-corruption laws. In the last three years, the Company
425
EX-10.1
KA
Kineta Inc
15 Dec 20
Business combination disclosure
7:32am
, directly or indirectly, that would result in a violation by
such persons of any applicable anti-corruption laws, including, without limitation, making … ) in violation of any applicable anti-corruption laws, and the Company and its subsidiaries have conducted their businesses in compliance
8-K
EX-10.1
KA
Kineta Inc
15 Dec 20
Yumanity Therapeutics to Raise $33.6 Million PIPE Contingent on Completion of Reverse Merger with Proteostasis
7:34am
, directly or indirectly, that would result in a violation by
such persons of any applicable anti-corruption laws, including, without limitation, making … ) in violation of any applicable anti-corruption laws, and the Company and its subsidiaries have conducted their businesses in compliance
425
KA
Kineta Inc
6 Jun 22
Business combination disclosure
4:05pm
Anti-Corruption Compliance; Trade Control Laws and Sanctions
2.13
Tax Matters
2.14
Employee Benefit Plans
2.15
Labor and Employment
2.16 …
Intellectual Property
3.7
Agreements, Contracts and Commitments
3.8
Liabilities
3.9
Compliance; Permits; Restrictions
3.10
Anti-Corruption Compliance
8-K
EX-10.2
meeb31xemqbh6i4a7hnm
30 Dec 20
Yumanity Therapeutics Completes Reverse Merger with Proteostasis Therapeutics
4:44pm
S-4
EX-10.19
o0r6i s193ui2u
23 Sep 20
Registration of securities issued in business combination transactions
4:50pm
8-K
EX-1.1
chw 1i1kbb8lgt1z7
8 Apr 21
Entry into a Material Definitive Agreement
9:06am
8-K
EX-1.1
kvdxr 5l7qhz3
24 Oct 18
Entry into a Material Definitive Agreement
4:28pm
8-K
EX-1.1
4b6rh
9 May 19
Entry into a Material Definitive Agreement
8:07am
8-K
EX-99.5
q6mnh107g5cw l7
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K/A
EX-99.1
rtos9cv00qvp6e 23t
3 Feb 21
Other Events
4:59pm